EP0159355A1 - Dispositif d'analyse quantitative rapide d'un fluide - Google Patents

Dispositif d'analyse quantitative rapide d'un fluide

Info

Publication number
EP0159355A1
EP0159355A1 EP19840903904 EP84903904A EP0159355A1 EP 0159355 A1 EP0159355 A1 EP 0159355A1 EP 19840903904 EP19840903904 EP 19840903904 EP 84903904 A EP84903904 A EP 84903904A EP 0159355 A1 EP0159355 A1 EP 0159355A1
Authority
EP
European Patent Office
Prior art keywords
catalyst
reagent
analyte
reaction product
substrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19840903904
Other languages
German (de)
English (en)
Inventor
Craig R. Hof
Robert B. Polak
Anthony Cerami
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INOMEDIX Inc
Original Assignee
INOMEDIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INOMEDIX Inc filed Critical INOMEDIX Inc
Publication of EP0159355A1 publication Critical patent/EP0159355A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/521—Single-layer analytical elements
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions

Definitions

  • This invention concerns devices for quantitative analysis of fluids which allows rapid, visual assays of analytes.
  • the devices are useful in assays of biological fluids for enzymes and enzyme substrates and in particular in specific binding assays involving enzymelinked reagents.
  • Diagnosis of disease may depend on the results of quantitative chemical analysis of a body fluid for a particular component.
  • Many methods are known today for analysis of body fluids such as blood and urine. They generally employ instruments which are very sensitive and accurate and are useful in detecting minute amounts of substances which may indicate disease. However, these instruments are expensive and require calibration, making them unsuitable for use outside a clinical laboratory.
  • Test strips have been devised which give observable color changes upon contact with fluids.
  • Glucose for example, may be monitored in urine by means of a chromogenic paper strip
  • test strips for assays of glucose and other substances in a fluid.
  • the test strips contain a plurality of reagent zones each of which contains a chemical reagent which reacts with the analyte resulting in the oxidation of an indicator to render the indicator colored.
  • Each zone also contains a substance which consumes one of the reactants necessary for color formation. Since each zone contains an incrementally different amount of the substance, the test strip can quantify the concentration range of the analyte present in the fluid.
  • Hochstrasser does not disclose a means for preventing interference from substances such as hemoglobin.
  • Hochstrasser does not disclose any internal means for standardizing the test strips against variations in the temperature of the fluid to be tested or in the time period in which the strip is contacted with the fluid. Overexposure of the device to the fluid, therefore, can produce a significant level of false positive results. More prolonged contact with the fluid can exhaust the quantifying substance and extinguish quantification completely.
  • This invention concerns simple, rapid methods and devices for carrying out such methods to determine the presence of analyte in a fluid.
  • the device comprises s support member impregnated with a first catlyst, e.g. an enzyme, for the production of a dectable product and a compensater means for inhibiting the first catalyst at a predetermined rate.
  • a first catlyst e.g. an enzyme
  • Another device is useful for determining the presence of an enzyme for the reaction of a substrate of the enzyme with a first reagent to produce a dectable reaction product in a fluid containing the first reagent.
  • This device comprises a support member impregnated with the substrate of the enzyme and a compensator means for inhibiting the enzyme at a predetermined rate.
  • Another embodiment provides a device for determining the presence of an analyte containing a first reagent, a second reagent capable of reacting with the first reagent the second reagent being a substrate for a first catalyst for the production of the detectable reaction product and the first catalyst being bound to the analyte.
  • the device comprises a support member impregnated with a biochemical reagent capable of binding to the analyte and a compensator means for inhibiting the first catalyst at a predetermined rate.
  • This device is useful in specific binding assays, e.g. in immunoassays or as a DNA probe.
  • the various devices of .this invention are designed for the production of a first reaction product, e.g. the detectable reaction product. This product may but need not absorb visible light.
  • the devices of this invention may also comprise a second catalyst, e.g. an enzyme, for the reaction of the first reaction product with an indicator reagent to produce a compound which does absorb visible light.
  • the indiator reagent as well as other reagents may also be impregnated on the device or added to the fluid being tested.
  • the compensator means of this invention inhibits either the first catalyst or enzyme of the device, or the catalyst for the reaction of indicator reagent for producing the compound which absorbs visible light.
  • the compensator means is suitable catalytic comprising a second catalyst, with the fluid containing a substrate of the second catalyst and a second reagent, the reaction of the second reagent with the substrate for the second catalyst producing the inhibitor.
  • the substrate for the second catalyst may be impregnated on the device with the second catalyst in the fluid, or both the second catalyst and its substrate may be impregnated on the device.
  • the compensator means may comprise an inhibitor of the first catalyst or enzyme or an inhibitor of the catalyst for the reaction of .the indicator reagent for producing the compound which absorbs visible light, the inhibitor being encapsulated in a suitable material capable of releasing the inhibitor at a predetermined rate after the device contacts the fluid.
  • the compensator means of this invention serves to inhibit the relevant catalyst at a predetermined rate.
  • Devices of this invention may also comprise known amount of a quantifying reagent which reacts with the detectable reaction product or with the compound which absorbs visible light.
  • the device may comprise the aforementioned constituents in at least two discrete zones on the suppport member. Where the known amount of quantifying reagent in at least two of the zones is different, the device is useful in quantitatives assays since the two zones will indicated the presence of the analyte in different concentrations.
  • Figures 1A and 1B illustrate a device with a plurality of reagent zones, each of which contain an indicator reagent and an amount of quantifying means differing from zone to zone.
  • Figure 1A illustrates the device before contact with the fluid.
  • Figure 1B illustrates the device after contact with the fluid.
  • Three of the six zones show a change in the indicator reagent indicative of the presence of analyte in the fluid above a minimum concentration corresponding to the amount of quantifier in each of the three changed zones.
  • the device comprises a support member impregnated with a first catalyst, e.g. an enzyme for the production of the detectable product and a compensator means for inhibiting the first catalyst at a predetermined rate.
  • the enzyme is suitably an oxidoreductase, transferase, hydrolase, lyase, isomerase or ligase enzyme.
  • the support member of the device of this and other embodiments of the invention may comprise any suitable material into which the various components and reagents may be impregnated.
  • Insoluble polymers for example, of cellulosics, acrylics, polyester or ceramics are suitable.
  • the components may be impregnated into the matrix formed by the support material or may be immobilized upon the support member with suitable binding agents by conventional methods.
  • the first catalyst is an enzyme which catalyzes the production of a detectable reaction product which may then be detected either directly, e.g. if the product is a compound which absorbs visible light, or indirectly with an indicator reagent as disclosed herein.
  • the analyte is an enzyme
  • the support member is suitably impregnated with an appropriate substrate of the enzyme.
  • the enzyme may suitably be an oxidoreductase, transferase, hydrolase, lyase, isomerase or ligase enzyme.
  • the oxidoreductase enzyme is an enzyme capable of catalyzing the production of hydrogen peroxide, e.g.
  • glucose oxidase or cholesterol oxidase upon contact under suitable conditions with an appropriate substrate, e.g. glucose or cholesterol, respectively, in the presence of an appropriate first reagent, e.g. oxygen.
  • an appropriate substrate e.g. glucose or cholesterol
  • an appropriate first reagent e.g. oxygen
  • suitable buffers and ionic salts are added to the device or fluid to allow the enzymatic reaction to proceed.
  • the compensator means serves as an internal standard to control the extent to which the catalytic production of the detectable product proceeds by inhibiting the first catalyst at a predetermined rate which may be temperature dependent.
  • the compensator means of the device of this and other embodiments is suitably a second catalyst, e.g. an enzyme, where the fluid contains a substrate for the second catalyst and a second reagent, the reaction of the second reagent with the substrate for the second catalyst producing an inhibitor of the first catalyst.
  • a second catalyst e.g. an enzyme
  • the compensator means suitably comprises a substrate for a second catalyst, where the fluid contains the second catalyst and a second reagent, the reaction of the second reagent with the substrate for the second catalyst likewise producing an inhibitor of the first catalyst.
  • the compensator means suitably comprises a second catalyst and a substrate for the second catalyst and the fluid contains the second reagent, the reaction of the second reagent with the substrate for the second catalyst, as above, producing an inhibitor of the first catalyst.
  • the catalytic reaction proceeds independently of and concurrently with the reaction of the first reagent and the analyte.
  • the compensator means of this invention does not generate enough inhibitor to substantially completely inhibit the first catalyst until after a sufficient time has passed for a detectable amount of the detectable reaction product to have been produced.
  • the amount of appropriate material for use as the compensator means can be chosen to predetermine the amount of time which will be allowed for the catalytic production of the detectable reaction product.
  • an amount of the second catalyst and its substrate necessary to generate this amount of inhibitor can be employed.
  • the time in which this amount of inhibitor is produced can be predetermined by a simple kinetic study. Therefore, by choosing an appropriate amount of materials, the time allowed for the first catalyst to function can be internally standardized. This internal compensation for time removes variables caused by time of reaction which simplifies testing procedures and allows reliable comparison of different assays.
  • the compensator means can also be an internal standard for temperature if the rate of generation of compensator product varies in a predictable fashion with the temperature.
  • the compensator means can also eliminate the need for external temperature control or standardization.
  • the second catalyst is suitably mandelonitrile lyase and the substrate for the second catalyst is mandelonitrile, where the second reagent is water and the inhibitor of the first catalyst produced by the reaction of the substrate and the second reagent is cyanide ion.
  • the second catalyst is suitably betaglucosidase
  • the substrate for the second catalyst is amygdalin
  • the second reagent is water
  • the inhibitor of the first catalyst produced by the reaction of the second reagent is cyanide ion.
  • the first catalyst of this invention Numerous and varied other enzymes for catalyzing the production of a detectable product which are not inhibited by cyanide are also known in the art and useful as the first catalyst of this invention.
  • a suitable enzyme for catalyzing the production of an appropriate inhibitor e.g. a sulfide, a specific amino acid or other substance, can readily be selected from those known in the art for use as the second catalyst for the compensator means.
  • the compensator means is an inhibitor of the first catalyst encapsulated in a suitable material capable of releasing the inhibitor at a predetermined rate after the device contacts the fluid.
  • Suitable materials include porous materials and materials which decompose gradually or within a predetermined period of time, which in either case permit the release of the contained inhibitor at a predetermined rate.
  • Suitable materials and methods for encapsulation are known. See e.g., U.S. Patent Nos. 3,092,463 (1963); 3,252,762 (1966); 3,240,117 (1966) and 3,341,466 (1967).
  • Suitable inhibitors for many enzymes are also known, see e.g. The Enzymes, 3rd Ed., Academic Press, New York (1971); Enzyme Handbook, Vols. I and II, (Barman, T.E. Ed.) Springer-Verlag New York Inc.
  • the catalytic production of the detectable reaction product is a multi-step process, each step of which may be catalyzed by a different catalyst and require a different additional reagent.
  • the catalyst to serve as the first catalyst of this invention i.e. the catalyst which will be inhibited by the compensator means, may be selected on the basis of convenience in inhibiting the catalyst.
  • the detectable reaction product in one embodiment is a compound which absorbs visible light.
  • the device is also impregnated with a second catalyst for the reaction of the detectable reaction product with an indicator reagent to produce a compound which absorbs visible light.
  • the device may also be impregnated with a suitable amount of the indicator reagent.
  • the indicator reagent may be added to the fluid. Suitable indicator reagents include redox, pH or chelometric indicators.
  • the indicator reagent is preferably a chromogen which undergoes a color change in the catalyzed reaction.
  • the indicator reagent may undergo a density change or other visually observable physical change. If the device is to be used in a laboratory or clinic, the catalytic product of the indicator reagent and the detectable reaction product may be observed by instrumental methods.
  • components of blood or urine such as glucose or triglycerides can be caused to form hydrogen peroxide upon contact under suitable conditions with glucose oxidase or lipase, glycerol kinase or GP oxidase (or alternatively lipase and glycerol dehydrogenase), respectively.
  • the peroxide may be measured by the method and device of the present invention as set forth herein.
  • the indicator reagent is the redox indicator phenylenediamine.
  • m-aminosalicylic acid and numerous other indicator reagents known in the art, including for example o-dianisidine, p-toluidine, o-toluidine, p-diphenylamine sulfonic acid and N,Ndimethylindoaniline. See e.g. U.S. Patent Nos. 4,059,407 (1977) and 4,391,906 (1983).
  • a device of this invention may also he impregnated with a known amount of a quantifying reagent which reacts with the detectable reaction product, thereby consuming it.
  • the quantifying reagent may suitably be a reducing agent, e.g. ascorbic acid or a salt thereof.
  • the detectable reaction product is pH-sensitive the quantifying reagent may suitably be a buffer.
  • a suitable quantifying reagent must be capable of inhibiting the accumulation of the detectable reaction product to a degree proportional to the amount of quantifying reagent impregnated on the device.
  • the device is impregnated with a quantifying reagent and a second catalyst for the reaction of the detectable reaction product with an appropriate indicator reagent to produce a compound which absorbs visible light.
  • the quantifying reagent is capable of competing with the indicator reagent and reacting with the detectable reaction product before that product can react with the indicator reagent.
  • the quantifying reagent may, for example, react faster with the product than does the indicator reagent, either because of a greater reaction rate constant or because of a higher concentration- It is possible also that the quantifier may have a more favorable reaction potential, e.g. oxidation potential., as in the case of redox reactions - than does the indicator reagent. Preferably, the quantifier should react essentially irreversibly with the product to prevent an observable, slow reaction of detectable reaction product with indicator. It should also be noted that the quantifying reagent may also be capable of reacting with and consuming a compound which absorbs visible light produced by the catalytic reaction of the indicator reagent and the detectable reaction product.
  • S is the analyte or other substrate of a first catalyst
  • E is the first catalyst (preferably an enzyme) which is impregnated in or immobilized on the device or is the material to be determined
  • P is the detectable reaction product
  • Q is the unreacted quantifying reagent
  • P' is an uncolored product derived from P, and Q' the consumed quantifier.
  • I is the indicator reagent which reacts to produce the I', the compound which absorbs visible light. I' may also react with Q to produce I.
  • the first catalyst, the compensator means and the quantifying reagent are suitably each present in at least two discrete zones on the support member and the amount of quantifying reagent in at least two of the zones is different.
  • Such a device is useful for indicating the presence of different concentrations of the analyte.
  • at least two of the zones may contain different components and indicate the presence of at least two different analytes.
  • the device may be constructed in any of the various physical forms known in the assay arts, e.g. in the form of a test strip with each zone located on a distinct region of the test strip.
  • the device may be a test plate with each reagent zone located in a distinct plate well.
  • a semipermeable barrier means e.g. by being coated laminated or otherwise firmly affixed with a semipermeable membrane material, to exclude substances capable of interfering with the operation of the device.
  • barrier means comprise a layer capable of excluding substances such as hemoglobin or red blood cells, and permit the use of devices of this invention in direct assays of whole blood.
  • Suitable material for such a layer is a polymer such as polyvinylacetate.
  • FIG. 1 A preferred embodiment of the present invention is given in Figure 1 wherein quantifier, indicator and catalysts are located in discrete zones on the support member. Other embodiments may comprise different geometrical arrangements and shapes of areas where indicator and quantifier are affixed. Some or all of the areas may also be contiguous. Alternatively, the areas may be affixed to separate surfaces which are superimposed.
  • the device may be employed to determine quantitatively the concentration of an analyte which is a substrate of a catalyst, an enzyme, for example. In this procedure the solution containing an unknown amount of analyte is contacted with the first catalyst impregnated on the support member of the device along with appropriate buffers and ionic salts, or these reagents may be added independently to the sample while it is being analyzed.
  • the analyte produces a detectable reaction product and may react with an indicator reagent if provided, to produce a compound which absorbs visible light in a reaction catalyzed by a second catalyst. Either type of product may be consumed completely or partially in a reaction with the quantifier means. All of the reactions must occur within the time determined by the compensator means, i.e., before the inhibition of the first catalyst is substantially complete.
  • the reaction zjone(s) are then monitored for detectable changes, i.e. the presence of the detectable product or the compound which absorbs light, and the identity and number of the zone(s) that change are correlated with amount of analyte present in the fluid.
  • This procedure is especially useful in measurement of glucose, triglycerides or other components of body fluids which produce, or can be coupled to other chemical reaction systems that produce hydrogen peroxide upon contact with suitable chemical or enzymatic catalysts.
  • the hydrogen peroxide thus produced is generally observed by its reaction with an appropriate indicator in the presence of a peroxidase enzyme.
  • this amount of hydrogen peroxide may be determined quantitatively by contacting it with the device wherein the quantifying reagent is a keto enol tautomer, ascorbic acid, for example, the indicator reagent is a chromagen such as phenylenediamine and the compensator means, mandelonitrile, in combination with mandelonitrile lyase, f.or example, produces cyanide ion.
  • the quantifying reagent is a keto enol tautomer, ascorbic acid
  • the indicator reagent is a chromagen such as phenylenediamine
  • the compensator means mandelonitrile, in combination with mandelonitrile lyase, f.or example, produces cyanide ion.
  • the compensator means may suitably function by inhibiting the second catalyst.
  • a device for determining the presence of an analyte in a fluid containing a first reagent capable of reacting with the analyte to produce a detectable reaction product will thus comprise a support member impregnated with a first catalyst for the production of the detectable product, a second catalyst for the reaction of the detectable reaction product with an indicator reagent to produce a compound which absorbs visible light and a compensator means for inhibiting the second catalyst at a predetermined rate.
  • Such a device may also be impregnated with the indicator reagent, or such reagent may be added to the fluid separately.
  • the compensator means encompasses each of the previously described compensator means differing only in that the inhibitor so produced is in this embodiment an inhibitor of a second catalyst for the reaction, with an. indicator reagent.
  • I* Compound which absorbs visible light
  • I Indicator reagent (uncolored)
  • the compensator means using amygdalin and glucosidase can be replaced by one using mandelonitrile and mandelonitrile lyase to produce CN-.
  • the amount of peroxide present may be read out from the device and correlated to the amount of peroxide-generating analyte in the sample.
  • Quantitative assay of large numbers of other diagnostically significant components which generate peroxide may also be determined quickly, simply and reliable by this method and device.
  • the quantifying reagent may be a buffering substance and the compensator means may inhibit the first, pH changing catalyst or enzyme.
  • the device is also useful in determining the quantities of various metabolites (urea, creatinine, etc.) and other substances (glucose, ethanol, etc.) found in biological fluids. See e.g., U.S. Patent No. 4,059,407 (1977).
  • a device of this invention is also useful for determining the presence of an enzyme for the reaction of a substrate with a first reagent to produce a detectable reaction product in a fluid containing the first reagent.
  • the device comprises a support member impregnated with the substrate of the enzyme and a compensator means for inhibiting the enzyme at a predetermined rate.
  • Such a device may also be impregnated with an indicator reagent capable of reacting with the detectable reaction product to produce a compound which absorbs visible light and a catalyst for the reaction of the indicator reagent with the detectable reaction product.
  • the indicator reagent may be separately added to the fluid.
  • Enzyme assay devices of this invention may also be impregnated with an appropriate quantifying reagent and may be constructed with a plurality of zones for the detection of different levels of enzyme activity in an analogous fashion to the analyte assay devices previously discussed.
  • Such enzyme assay devices may also be coated with a semipermeable membrane material and are useful for numerous assays of clinical significance including assays for alkaline phosphatase, acid phosphatase, lipase, amylase, aspartate aminotransferase or glutamate oxalacetate transferase, alanine aminotransferase or glutamate pyruvate transferase, lactate dehydrogenase and creatine kinase or creatine phosphokinase.
  • a device of this invention is also suitable for use in specific binding assays, e.g. immunoassays or nucleotide probes, involving appropriately labeled reagents, e.g. reagents labeled with an enzyme.
  • specific binding assays e.g. immunoassays or nucleotide probes
  • reagents e.g. reagents labeled with an enzyme.
  • Methods for linking enzymes to various reagents including monoclonal or serum antibodies, antigens, haptens and nucleotide sequences and methods for using such enzyme-linked reagents in various assays for numerous and varied analytes are known in the art, see e.g. Renz, M. et al., Acids Res. 12:3435-3444 (1984) and U.S. Patent Nos.
  • the component of the antigenantibody pair which contains an enzyme label is contacted with the device comprising a compensator means and one or more of substrate, indicator reagent and quanti fying reagent.
  • the device may contain a plurality of discrete zones on the support member, the number and identity of zones in which a reaction is detected during the assay being a measure of the amount of enzyme and therefore of the amount of analyte being assayed. No comparison to a standard or control is necessary and variables due to the time of reaction, temperature and subjectivity of color measurements are eliminated. A reliable, simple immunoassay is thus provided.
  • One embodiment is a binding assay device for determining the presence of an analyte in a fluid containing a first reagent and a second reagent capable of reacting with the first reagent to produce a detectable reaction product, the second reagent being a substrate for a first catalyst and the first catalyst being bound to the analyte.
  • the device comprises a support member impregnated with a biochemical reagent capable of binding the analyte and a compensator means capable of inhibiting the first catalyst at a predetermined rate.
  • the catalyst is suitably bound to the analyte by means of a second biochemical reagent, e.g. an antibody to the analyte, for use in a sandwich assay.
  • a second biochemical reagent e.g. an antibody to the analyte
  • the catalyst may suitably be bound directly to a known amount of the analyte, i.e. a molecule of the substance to be determined, for use in a homogeneous or heterogeneous competitive binding assay.
  • the analyte is an antigen and the biochemical reagent is an antibody to the antigen.
  • Antigen as the term is used herein, is also meant to encompass haptens.
  • the antigen is, or is derived from, a virus, bacterium, fungus, yeast, cancer cell or other disease causing agent, therapeutic drug. drug of abuse, hormone or other protein.
  • analyte is a ligand and the biochemical reagent is a receptor capable of binding the ligand.
  • the analyte is a nucleic acid sequence and the biochemical reagent is a complementary sequence.
  • the compensator means for such a device suitably comprises a substrate for a second catalyst where the fluid contains the second catalyst and a second reagent, the reaction of the second reagent with the substrate for the second catlayst producing an inhibitor of the first catalyst.
  • the compensator means may comprise the second catalyst and the substrate for the second catalyst where the fluid contains the second reagent.
  • the compensator means may also comprise the second catalyst where the fluid contains the substrate for the second catalyst and the second reagent.
  • Suitable second catalysts and substrates therefor are as previously discussed and include mandelonitrile lyase and mandelonitrile, respectively, and amygdalin and beta glucosidase, respectively, where the first catalyst is inhibited by cyanide ion.
  • a suitable second catalyst preferably an enzyme, and a substrate and second reagent therefor capable of catalytically producing such substance may be selected from those known in the art.
  • the compensator means may further comprise an inhibitor of the first catalyst encapsulated in a suitable material capable of releasing the inhibitor at a predetermined rate after the device contacts the fluid.
  • the detectable reaction product may be a compound which absorbs visible light.
  • the device may also be impregnated with a second catalyst for the reaction of the detectable reaction product with an indicator reagent to produce a compound whcih absorbs visible light.
  • the device may also be impregnated with a suitable amount of the indicator reagent or the indicator reagent may be added to the fluid.
  • the device may also be impregnated with a known amount of a quantifying reagent which reacts with the detectable reaction product.
  • the biochemical reagent, the compensator means and the quantifying reagent are each present in at least two discrete zones on the support member and the amount of quantifying reagent in at leat two zones is different.
  • Such a device is therefore useful in quantitative assays.
  • the impregnated support member may also be coated with or laminated with a semipermeable membrane material. Such material can be selected to prevent the constituents of the support member from contacting interfering substances in the fluid, such as red blood cells or hemoglobin.
  • the first catalyst bound to the analyte catalyzes, upon subsequent contact with an appropriate substrate and reagent the production of the detectable reaction product.
  • the first catalyst is an enzyme, e.g. an oxidoreductase, transferase, hydrolase, lyase, isomerase or ligase enzyme.
  • the substrate for the first catalyst is also present on the support member, but is encapsulated in a suitable material or otherwise kept from contacting the first catalyst until the device is contacted with the fluid.
  • the support member may further comprise a removably mounted, permeable layer containing a suitable amount of the analyte to which the first catalyst is bound.
  • a layer is suitably capable of permitting the first catalyst bound to the analyte to diffuse to at least one zone of the support under suitable conditions.
  • Whatman No. 1 paper is suitable for use as the permeable layer.
  • the devices of this invention are useful in various assay methods and are adaptable to a broad range of conventional assay techniques.
  • One method. is useful for determining the presence of an analyte in a fluid containing a first reagent capable of reacting with the analyte to produce a detectable reaction product.
  • the method comprises contacting the fluid with a first catalyst for the reaction of the analyte with the first reagent to produce the detectable reaction product and with a compensator means for inhibiting the first catalyst under suitable conditions permitting the first catalyst to catalyze the reaction and permitting the compensator means to inhibit the first catalyst at predetermined rates.
  • the presence of the analyte in the fluid is determined.
  • detection can be effected by visually observing the appearance of the compound.
  • One method of this invention is useful for determining the presence of an enzyme in a fluid containing a first reagent capable of reacting with a substrate of the enzyme to produce a detectable reaction product.
  • the method involves contacting the fluid with the substrate of the enzyme for the production of the detectable reaction product and with a compensator means for inhibiting the enzyme.
  • the contacting is effected under suitable conditions for the enzyme to catalyze the reaction and the compensator means to inhibit the enzyme at predetermined rates.
  • the presence of the enzyme in the fluid is thereby determined.
  • Another method is useful for determining the presence of an analyte at a concentration greater than a predetermined concentration in a fluid containing a first reagent capable of reacting with the analyte to produce a detectable reaction product.
  • This method involves contacting the fluid with a first catalyst for the production of the detectable reaction product, with a known amount of a quantifying reagent capable of react ing with and thereby consuming an amount of the detectable reaction product corresponding to the predetermined concentration of the analyte and with a compensator means for inhibiting the first catalyst.
  • the contacting is effected under suitable conditions permitting the first catalyst to catalyze the production of the detectable reaction product, the quantifying reagent to consume the detectable reaction product and the compensator means to inhibit the first catalyst at predetermined rates.
  • the presence of the detectable reaction product By detecting the presence of the detectable reaction product, the presence of the analyte in the fluid at a concentration greater than the predetermined concentration can be determined.
  • Another embodiment also concerns a competitive binding assay method for determining the presence or concentration of a given analyte in a fluid.
  • This method involves a device of this invention containing a removably-mounted permeable layer containing labeled analyte, as previously mentioned.
  • the method involves contacting the device with the fluid, the contacting being under suitable conditions and for a sufficient period of time permitting analyte in the fluid and the labeled analyte in the removably mounted, permeable layer to diffuse to at least one reaction zone and permitting the analyte and the labeled analyte to bind competitively with the biochemical reagent in the reaction zones of the device; removing excess fluid and labeled analyte from the device after a suitable period of time e.g.
  • reaction zone(s) of the device by washing or blotting; contacting the reaction zone(s) of the device with a suitable amount of an appropriate substrate of the reaction reagent label under suitable conditions permitting the substrate to react with the reaction reagent of the labeled analyte to produce a reaction product, identifying the reaction zone(s) in which the presence of the reaction product is detected, and correlating the zones identified with the concentration of the analyte in the fluid.
  • Another method is a heterogeneous binding assay for determining the presence of an analyte in a fluid containing a first reagent capable of reacting with a substrate of a first catalyst to produce a detectable reaction product.
  • This method involves adding to the fluid a first known amount of the first catalyst to which a second known amount of the analyte is bound The resulting fluid is then contacted with a biochemical reagent capable of binding to the analyte under suitable conditions so as to form a complex thereof. The complex is separated from uncomplexed first catalyst to which the analyte is bound, e.g.
  • Another method of this invention is a homogeneous assay for determining the presence of an analyte in a fluid containing a first reagent capable of reacting with a substrate of a first catalyst to produce a detectable reaction product.
  • This method involves adding to the fluid a first known amount of the first catalyst to which a second known amount of the analyte is bound.
  • the resulting fluid is then contacted with a biochemical reagent capable of binding to the analyte under suitable conditions to as to form a complex.
  • the catalytic activity of a suitable first catalyst bound to uncomplexed analyte is detectably greater than the catalytic activity of the first catalyst bound to complexed analyte, as in prior homogeneous assay methods.
  • the fluid is then contacted with the substrate of the first catalyst and with a compensator means for inhibiting the first catalyst under suitable conditions permitting the first catalyst to catalize the production of the detectable reaction product and the compensator means to inhibit the first catalyst at predetermined rates.
  • a compensator means for inhibiting the first catalyst under suitable conditions permitting the first catalyst to catalize the production of the detectable reaction product and the compensator means to inhibit the first catalyst at predetermined rates.
  • Another method is useful for determining the presence of an analyte in a fluid containing a first reagent capable of reacting with a substrate of a first catalyst to produce a detectable reaction product.
  • This method is a sandwich technique and involves adding to the fluiddd a first biochemical reagent and the first catalyst to which a second biochemical reagent is bound, both biochemical reagents being capable of binding to the analyte under suitable binding conditions to produce a complex comprising the analyte bound to both biochemical reagents.
  • the complex is separated from uncomplexed first catalyst to which the second biochemical reagent is bound.
  • the separated complex is then contacted with the substrate of the first catalyst- in the presence of a compensator means for inhibiting the first catalyst under suitable conditions permitting the first catalyst to catalyze the production of the detectable reaction product and the compensator means to inhibit the first catalyst at predetermined rates.
  • a devioe comprising a support member impregnated with a first catalyst for the production of a detectable reaction product and- a compensator means for inhibiting the first catalyst at a predetermined rate, as previously described, can be used.
  • the device is contacted with the fluid, removed the device from the fluid and. the presence of the detectable reaction production detected on the device. The presence of the analyte in the fluid is thereby determined.
  • Another method is of general utility for controlling the catalytic reaction of a reagent and a substrate for a catalyst.
  • the method comprises contacting the reagent with the substrate for the catalyst, the catalyst and a compensator means under suitable conditions permitting the catalyst to catalyze the reaction and the compensator means to inhibit the catalyst at predetermined rates, in accordance with this invention.
  • This example illustrates the preparation of a device to determine blood glucose.
  • the five paper strips prepared above were sliced into l/8" wide strips and fixed onto a heavy plastic sheet previously coated with a pressure sensitive adhesive. The combined assembly was then cut into 1/8" strips containing five discrete zones. Each zone was designated #1, #2, #3, #4 or #5, corresponding to the paper strip of the same number from which the zone was prepared. These devices were stored with dessicanta in a sealed container.
  • Example I The device prepared in Example I was used in an assay of glucose in whole blood as follows:
  • a drop of blood was applied to each of the five zones of the device from Example 1. After about two minutes, the blood was wiped away with a moist paper towel. When the blood specimen contained 120 mg/dl glucose, zones 1 and 2 became reddish-orange in color while 3-5 remained off-white.
  • the corresponding glucose concentration readout for zone segment is:
  • a device for determining blood glucose was prepared as follow. Solutions A, B, C and D were prepared as indicated below:
  • Solution B 1 0.014 cc of Solution D was added to 5 cc of Solution B
  • Solution B 2 0.042 cc of Solution D was added to 5 cc of Solution B
  • Solution B 3 0.070 cc of.
  • Solution D was added to 5 cc of Solution B
  • Example IV The paper strips prepared as above were sliced into 1/8" wide strips which were then used to prepare a quantitative device as in Example I, but containing three zones designated #1, #2 and #3, corresponding to the paper strip of the same number from which each zone was prepared.
  • Example IV The paper strips prepared as above were sliced into 1/8" wide strips which were then used to prepare a quantitative device as in Example I, but containing three zones designated #1, #2 and #3, corresponding to the paper strip of the same number from which each zone was prepared.
  • Example III The device prepared in Example III was used in an assay of glucose in whole blood.
  • the assay method of Example II was followed. Zone #1 turned red when the glucose concentration was above 80 mg/dl, #2 when above 110 mg/dl and #3 when above 140 mg/dl.
  • HCG human corionic gonodatropin
  • anhydride containing polymer such as Gantrez AN 11% (available from GAF Corporation) in anhydrous dimethyl sulfoxide (DMSO) to couple the protein to the polymer.
  • DMSO dimethyl sulfoxide
  • Mandelonitrile lyase is also coupled to the polymer at the same time.
  • the mandelonitrile lyase is the internal time and temperature compensator. The coupling reaction requires from one to five days at room temperature depending on the concentration of reactants.
  • 1,4 butonediol is added to the DMSO solution as a crosslinking agent for the Gantrez.
  • Strips of Whatman #1 filter paper are immersed in the DMSO solution, removed and drained of excess solution and held under N 2 for about three to five days at room temperature until the crosslinking is completed.
  • the strips are then immersed in an aqueous 1M phosphate buffer at pH about 7.4 for three days to hydrolyze any unreacted anhydride remaining in the Gantrez backbone. Finally, the strips are immersed in a solution of sodium ascorbate, are dried under vacuum, mounted on plastic support pieces and cut into test strips.
  • a specimen of human urine is collected for analysis.
  • Human HCG labeled with horseradish peroxidase is added to the urine, and the test strip is placed in the urine sample for about 20 minutes.
  • a developing solution is prepared containing H 2 O 2' phenylenediamine, and mandelonitrile. Excess fluid is blotted from the test strip and several drops of developing solution are put onto the test strip. After about five minutes, the color of the paper test area is examined. A reddish-brown color is a negative indication for pregnancy while an unchanged test area is positive.

Abstract

Dispositifs, p.ex. une bande de papier de test, et procédés utilisant ces dispositifs pour déterminer la présence d'un analyte dans un fluide. Un mode de réalisation utilise un dispositif contenant un premier réactif capable de réagir avec l'analyte pour produire un produit de réaction détectable qui comprend un organe de support imprégné avec un premier catalyseur, p.ex. une enzyme, pour la production du produit détectable et des moyens de compensation pour inhiber le premier catalyseur. Les dispositifs de cette invention peuvent également être imprégnés avec un réactif indicateur et un second catalyseur pour la production d'un composé qui absorbe la lumière visible facilitant ainsi la détection. Dans un mode de réalisation, les moyens de compensation inhibent le second catalyseur. Les dispositifs peuvent également être imprégnés avec une quantité connue d'un réactif de quantification qui consume le produit de réaction détectable. Le dispositif peut receler plus d'une zone contenant ces constituants, au moins deux zones pouvant contenir différentes quantités du réactif de quantification permettant l'utilisation du dispositif pour des analyses quantitatives. Des modes de réalisation de cette invention peuvent être utilisés dans diverses analyses de liaison spécifiques, p.ex. pour diverses analyses immunologiques ou comme sondes ADN. De nombreux analytes d'intérêt clinique peuvent être analysés à l'aide de ces dispositifs et procédés, y compris les enzymes du sang, les substrats pour des antigènes enzymatiques, des haptènes et autres substances.
EP19840903904 1983-10-17 1984-10-17 Dispositif d'analyse quantitative rapide d'un fluide Withdrawn EP0159355A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54260183A 1983-10-17 1983-10-17
US542601 1983-10-17

Publications (1)

Publication Number Publication Date
EP0159355A1 true EP0159355A1 (fr) 1985-10-30

Family

ID=24164522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840903904 Withdrawn EP0159355A1 (fr) 1983-10-17 1984-10-17 Dispositif d'analyse quantitative rapide d'un fluide

Country Status (4)

Country Link
EP (1) EP0159355A1 (fr)
JP (1) JPS61500152A (fr)
AU (1) AU3552284A (fr)
WO (1) WO1985001747A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU560779B2 (en) * 1985-01-24 1987-04-16 Quidel Assay for drugs of abuse
US4746631A (en) * 1985-05-09 1988-05-24 Ultra Diagnostics Corporation Immunoassay method, device, and test kit
US6395227B1 (en) 1989-08-28 2002-05-28 Lifescan, Inc. Test strip for measuring analyte concentration over a broad range of sample volume
US5620863A (en) * 1989-08-28 1997-04-15 Lifescan, Inc. Blood glucose strip having reduced side reactions
US5843691A (en) * 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
US5962215A (en) * 1996-04-05 1999-10-05 Mercury Diagnostics, Inc. Methods for testing the concentration of an analyte in a body fluid
US20020010406A1 (en) 1996-05-17 2002-01-24 Douglas Joel S. Methods and apparatus for expressing body fluid from an incision
EP1579814A3 (fr) 1996-05-17 2006-06-14 Roche Diagnostics Operations, Inc. Procedes et appareil de prelevement et d'analyse de liquide organique
DE29723400U1 (de) * 1996-10-30 1998-09-10 Mercury Diagnostics Inc Synchronisiertes Anlayt-Testsystem
US5948695A (en) * 1997-06-17 1999-09-07 Mercury Diagnostics, Inc. Device for determination of an analyte in a body fluid
AUPQ826500A0 (en) 2000-06-21 2000-07-13 Novapharm Research (Australia) Pty Limited Enzyme detection and measurement
JPWO2012111328A1 (ja) * 2011-02-15 2014-07-03 鷹仁 松村 尿検査シート

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092465A (en) * 1960-03-25 1963-06-04 Miles Lab Diagnostic test device for blood sugar
US3814668A (en) * 1969-10-15 1974-06-04 Miles Lab Method and device for the semi-quantitative determination of glucose in aqueous fluids
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3964871A (en) * 1974-12-18 1976-06-22 Becton, Dickinson And Company Method and device for detecting glucose
US4218535A (en) * 1976-03-16 1980-08-19 Beckman Instruments, Inc. Determination of enzyme substrate concentration
US4038485A (en) * 1976-03-18 1977-07-26 Miles Laboratories, Inc. Test composition, device, and method
US4059407A (en) * 1976-04-14 1977-11-22 Becton, Dickinson And Company Disposable chemical indicators
JPS587332Y2 (ja) * 1978-06-06 1983-02-08 富士写真フイルム株式会社 多層血液化学分析材料
US4234680A (en) * 1979-08-03 1980-11-18 Calbiochem-Behring Corp. Method for terminating a peroxidase catalyzed reaction
US4341866A (en) * 1980-06-02 1982-07-27 Syva Company Antienzyme termination in enzyme immunoassays
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4442204A (en) * 1981-04-10 1984-04-10 Miles Laboratories, Inc. Homogeneous specific binding assay device and preformed complex method
US4390343A (en) * 1981-07-06 1983-06-28 Miles Laboratories, Inc. Multilayer analytical element having an impermeable radiation diffusing and blocking layer
JPS5847491A (ja) * 1981-09-18 1983-03-19 Ajinomoto Co Inc β−Ｄ−ガラクトシダ−ゼ作用の停止方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8501747A1 *

Also Published As

Publication number Publication date
WO1985001747A1 (fr) 1985-04-25
AU3552284A (en) 1985-05-07
JPS61500152A (ja) 1986-01-30

Similar Documents

Publication Publication Date Title
US4391905A (en) System for the determination of glucose in fluids
US4340669A (en) System for the determination of glucose in fluids
EP0252747B1 (fr) Utilisation de phénols et d'anilines pour augmenter le taux d'oxydation de leuco-colorants par peroxydase
Self Enzyme amplification—a general method applied to provide an immunoassisted assay for placental alkaline phosphatase
EP1082614B1 (fr) Procede et dispositif de detection d'analytes dans des fluides
US4391906A (en) System for the determination of glucose in fluids
EP0103784B1 (fr) Substrats catalysés colorimétriques et fluorométriques pour déterminations enzymatiques de péroxydase
CN108107211B (zh) 用于改善的侧向流动测定法的单一垫条
JP2002540427A5 (fr)
EP0200540B1 (fr) Elément analytique et procédé pour la détermination de créatine-kinase isoenzyme
EP0159355A1 (fr) Dispositif d'analyse quantitative rapide d'un fluide
JPH0695954B2 (ja) クレアチニン又はクレアチンの測定要素及び測定方法
EP0317070A2 (fr) Système d'essai numérique colorimétrique quantitatif
US3349006A (en) Process and composition for the enzymatic determination of uric acid
KR960002559B1 (ko) 효소 역학의 자동측정 방법
EP0239222B1 (fr) Elément analytique contenant un composé photosensible et une couche de filtre et procédé d'utilisation
JP2955443B2 (ja) 分析要素及び分析物の検出方法
US4971918A (en) Reducible indicator compositions containing pyrogallol derivatives
JP2767049B2 (ja) 被分析物の存在を測定する分析方法及び試験組成物
Li et al. A novel analysis method for lactate dehydrogenase activity in serum samples based on fluorescence capillary analysis
CA2373264C (fr) Dosage redox par chimiluminescence en vue de l'evaluation quantitative d'analytes dans des echantillons biologiques
JPH0635966B2 (ja) チオール化合物を検出するのに有用な分析試薬、及びそれを用いた検出方法
US5084395A (en) Reducible indicator compositions containing pyrogallol derivatives
Babkina et al. Enzyme amperometric sensor for the determination of cholinesterase inhibitors or activators
EP0399127A1 (fr) Méthode immunochimique homogène de détermination des haptènes au moyen d'électrodes sélectives par rapport aux ions

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): AT BE CH DE FR GB LI LU NL SE

17P Request for examination filed

Effective date: 19851008

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19871103

RIN1 Information on inventor provided before grant (corrected)

Inventor name: POLAK, ROBERT, B.

Inventor name: CERAMI, ANTHONY

Inventor name: HOF, CRAIG, R.